Summary

Central nervous system (CNS) disorders represent one of the most complex and urgent challenges in modern medicine. Neurological and mental health conditions now affect billions of people globally and account for hundreds of millions of disability-adjusted life years, placing growing pressure on healthcare systems and research communities.

Advancing effective therapies in this field requires navigating unique scientific and operational barriers. CNS clinical trials must address complex neurobiology, heterogeneous disease presentation, limited predictive biomarkers, and the challenges of measuring neurological outcomes reliably. At the same time, the research landscape is evolving rapidly, driven by innovations such as digital biomarkers, neuroimaging, artificial intelligence, and decentralized trial models that improve patient access and data collection.

Global clinical research is also shifting geographically. While North America and Europe remain key hubs, Asia-Pacific is emerging as a fast-growing center for neuroscience trials, supported by expanding infrastructure, regulatory modernization, and large patient populations.

Southern Star Research’s white paper examines the global burden of CNS disease, the structure and phases of neurological clinical trials, and the strategic considerations shaping the future of brain health research. It highlights the collaboration required across academia, industry, regulators, and patient communities to accelerate therapeutic innovation.

To explore these insights in detail, download our free report.